Kano bans IV fluids at patent stores
Analysis based on 7 articles · First reported Aug 18, 2026 · Last updated Aug 18, 2026
The ban may reduce revenue for patent medicine stores offering these services, but it is unlikely to significantly affect major healthcare providers or the broader market. It reinforces regulatory oversight in Nigeria's private healthcare sector, potentially improving patient safety and trust.
The Nigeria — Kano State Government, through the Nigeria — Private Health Institutions Management Agency (PHIMA), has banned patent medicine stores from administering intravenous (IV) fluids and conducting blood transfusions across the state. The directive, announced by Acting Executive Secretary Khadijah Hussein-Sa id during a sensitisation workshop, classifies patent medicine stores as non-clinical retail outlets not authorized to perform invasive procedures. Violators face immediate closure and sanctions. The measure aims to protect residents from unsafe practices and strengthen regulation of private health facilities. PHIMA urged the public to report violations and encouraged compliance with approved standards.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard